Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study

1. Dummer, R.
2. Queirolo, P.
3. Gerard Duhard, P.
4. Hu, Y.
5. Wang, D.
6. de Azevedo, S.J.
7. Robert, C.
8. Ascierto, P.A.
9. Chiarion-Sileni, V.
10. Pronzato, P.
11. Spagnolo, F.
12. Mujika Eizmendi, K.
13. Liszkay, G.
14. de la Cruz Merino, L.
15. Tawbi, H.